NCT03300661

Brief Summary

The study is an open-label intervention non pharmacological Cohort Study without control arm in patients with Non Alcoholic Fatty Liver Disease (NAFLD) and in healthy subjects. The intervention in patients with NAFLD is educational, providing personalized suggestions to improve diet and physical activity; the intervention in healthy subjects is educational, providing general suggestions to improve diet and physical activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 3, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2019

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2019

Completed
Last Updated

May 23, 2019

Status Verified

May 1, 2019

Enrollment Period

1.9 years

First QC Date

September 28, 2017

Last Update Submit

May 22, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Weight loss

    A reduction of at least 3 Kg

    12 months

  • Body Mass Index (BMI) decrease

    A dicresae of at least 1Kg/m2

    12 months

  • Waist Circumference (WC) decrease

    A decrease of at least 1.5 cm

    12 months

Secondary Outcomes (3)

  • Blood sugar level decrease

    12 months

  • Blood cholesterol level decrease

    12 months

  • Blood triglycerides level dicrease

    12 months

Study Arms (1)

Mediterranean Style

EXPERIMENTAL

Educational intervention with personalized suggestions to improve diet and physical activity

Behavioral: Mediterranean Style

Interventions

After completion of a Food Frequency Questinnaire (FFQ) and the International Physical Activity Questionnaire (IPAQ), patients enrolled in the study undergo a personalized educational intervention by a registered dietician. During the intervention the dietician advice about the main errors in diet and physical activity (by FFQ and IPAQ) and chooses three aims in diet modification and one aim in physical activity improvement. Patients adherence is assessed by the same dietician every three months, using FFQ and IPAQ, and futher supports are provided. Total intervention lenght is twelve months.

Mediterranean Style

Eligibility Criteria

Age20 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Presence of Fatty Liver at ultrasonography

You may not qualify if:

  • Pregnancy;
  • Breast Feeding
  • Cirrhosis or End Stage Liver Disease
  • Fatty Liver due to Hepatic Diseases other than Non Alcoholic Fatty Liver disease
  • Concomitant severe clinical condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ASST Spedali Civili Brescia

Brescia, 25123, Italy

Location

Related Publications (1)

  • Zanini B, Benini F, Marullo M, Simonetto A, Rossi A, Cavagnoli P, Bonalumi A, Marconi S, Pigozzi MG, Gilioli G, Valerio A, Donato F, Castellano M, Ricci C. Mediterranean-Oriented Dietary Intervention Is Effective to Reduce Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: Results from an Italian Clinical Trial. Int J Clin Pract. 2024 Jan 25;2024:8861126. doi: 10.1155/2024/8861126. eCollection 2024.

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Study Officials

  • Chiara Ricci, MD. PhD

    Università degli Studi di Brescia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A single cohort of patients with NAFLD, without control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 28, 2017

First Posted

October 3, 2017

Study Start

June 13, 2017

Primary Completion

May 17, 2019

Study Completion

May 20, 2019

Last Updated

May 23, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations